Liberati, Altman, Tetzlaff et Mulrow, « The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration », PLOS Medicine, vol. 6, no 7, , e1000100 (PMID19621070, PMCID2707010, DOI10.1371/journal.pmed.1000100)
Mulrow, « The Medical Review Article: State of the Science », Annals of Internal Medicine, vol. 106, no 3, , p. 485–488 (PMID3813259, DOI10.7326/0003-4819-106-3-485)
Sacks, Berrier, Reitman et Ancona-Berk, « Meta-Analyses of Randomized Controlled Trials », New England Journal of Medicine, vol. 316, no 8, , p. 450–455 (PMID3807986, DOI10.1056/NEJM198702193160806)
Moher, Cook, Eastwood et Olkin, « Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement », The Lancet, vol. 354, no 9193, , p. 1896–1900 (PMID10584742, DOI10.1016/S0140-6736(99)04149-5, S2CID21826935)
« The PRISMA 2020 statement: an updated guideline for reporting systematic reviews », BMJ (Clinical Research Ed.), vol. 372, , n71 (PMID33782057, PMCID8005924, DOI10.1136/bmj.n71)
« PRISMA 2020 explanation and elaboration: updated guidance and exemplars for reporting systematic reviews », BMJ (Clinical Research Ed.), vol. 372, , n160 (PMID33781993, PMCID8005925, DOI10.1136/bmj.n160)
Rethlefsen et et al. and PRISMA-S Group, « PRISMA-S: an extension to the PRISMA Statement for Reporting Literature Searches in Systematic Reviews. », Syst Rev., vol. 10, no 1, , p. 39 (DOI10.1186/s13643-020-01542-z)
Bhaumik et Lassi, « Vitamin D as an adjunct for acute community-acquired pneumonia among infants and children: systematic review and meta-analysis », WikiJournal of Medicine, vol. 4, no 1, (DOI10.15347/wjm/2017.005)
Moher, Liberati, Tetzlaff et Altman, « Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement », PLOS Medicine, vol. 6, no 7, , e1000097 (PMID19621072, PMCID2707599, DOI10.1371/journal.pmed.1000097)
Moher, Liberati, Tetzlaff et Altman, « Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement », BMJ, vol. 339, , b2535 (PMID19622551, PMCID2714657, DOI10.1136/bmj.b2535)
Moher, Liberati, Tetzlaff et Altman, « Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement », Journal of Clinical Epidemiology, vol. 62, no 10, , p. 1006–1012 (PMID19631508, DOI10.1016/j.jclinepi.2009.06.005, hdl2434/211629)
Moher, Liberati, Tetzlaff et Altman, « Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement », International Journal of Surgery, vol. 8, no 5, , p. 336–341 (PMID20171303, DOI10.1016/j.ijsu.2010.02.007)
Regona, M.et al Opportunities and Adoption Challenges of AI in the Construction Industry: A PRISMA Review. J. Open Innov. Technol. Mark. Complex. 2022, 8, 45. https://doi.org/10.3390/joitmc8010045
handle.net
hdl.handle.net
Moher, Liberati, Tetzlaff et Altman, « Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement », Journal of Clinical Epidemiology, vol. 62, no 10, , p. 1006–1012 (PMID19631508, DOI10.1016/j.jclinepi.2009.06.005, hdl2434/211629)
Liberati, Altman, Tetzlaff et Mulrow, « The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration », PLOS Medicine, vol. 6, no 7, , e1000100 (PMID19621070, PMCID2707010, DOI10.1371/journal.pmed.1000100)
Mulrow, « The Medical Review Article: State of the Science », Annals of Internal Medicine, vol. 106, no 3, , p. 485–488 (PMID3813259, DOI10.7326/0003-4819-106-3-485)
Sacks, Berrier, Reitman et Ancona-Berk, « Meta-Analyses of Randomized Controlled Trials », New England Journal of Medicine, vol. 316, no 8, , p. 450–455 (PMID3807986, DOI10.1056/NEJM198702193160806)
Moher, Cook, Eastwood et Olkin, « Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement », The Lancet, vol. 354, no 9193, , p. 1896–1900 (PMID10584742, DOI10.1016/S0140-6736(99)04149-5, S2CID21826935)
« The PRISMA 2020 statement: an updated guideline for reporting systematic reviews », BMJ (Clinical Research Ed.), vol. 372, , n71 (PMID33782057, PMCID8005924, DOI10.1136/bmj.n71)
« PRISMA 2020 explanation and elaboration: updated guidance and exemplars for reporting systematic reviews », BMJ (Clinical Research Ed.), vol. 372, , n160 (PMID33781993, PMCID8005925, DOI10.1136/bmj.n160)
Moher, Liberati, Tetzlaff et Altman, « Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement », PLOS Medicine, vol. 6, no 7, , e1000097 (PMID19621072, PMCID2707599, DOI10.1371/journal.pmed.1000097)
Moher, Liberati, Tetzlaff et Altman, « Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement », BMJ, vol. 339, , b2535 (PMID19622551, PMCID2714657, DOI10.1136/bmj.b2535)
Moher, Liberati, Tetzlaff et Altman, « Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement », Journal of Clinical Epidemiology, vol. 62, no 10, , p. 1006–1012 (PMID19631508, DOI10.1016/j.jclinepi.2009.06.005, hdl2434/211629)
Moher, Liberati, Tetzlaff et Altman, « Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement », International Journal of Surgery, vol. 8, no 5, , p. 336–341 (PMID20171303, DOI10.1016/j.ijsu.2010.02.007)
Moher, Cook, Eastwood et Olkin, « Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement », The Lancet, vol. 354, no 9193, , p. 1896–1900 (PMID10584742, DOI10.1016/S0140-6736(99)04149-5, S2CID21826935)
unistra.fr
cfrps.unistra.fr
Gedda, M, « Traduction française des lignes directrices PRISMA pour l'écriture et la lecture des revues systématiques et des méta-analyses », BMJ, 339, (lire en ligne [PDF])